News & Updates
As you may have heard from recent news reports, the U.S. Centers for Disease Control and Prevention (CDC) recently confirmed the first two cases of Ebola Virus Disease (Ebola), diagnosed at a hospital in Dallas, Texas.
The health and well-being of UnitedHealthcare's members is a top priority of theirs. In addition, the safety of those who deliver care - physicians, clinicians and nurses - are also a key concern.
UnitedHealthcare's clinical leadership is engaged with key health authorities, providers and others to closely monitor this evolving situation and support the needs of the people we serve.
Following CDC Guidance
As with any public health issue, UnitedHealthcare will work with and follow all guidance and protocols issued by the CDC, state and local public health departments in supporting their members' needs.
Currently, there is no FDA-approved vaccine or medication specific to Ebola. Recovery from Ebola depends on early intervention, good supportive care and the patient's immune response.
At this time, testing for Ebola can only be done at the direction of and in direct consultation with state and public health departments and the CDC. Although the chances are very low, if a UnitedHealthcare member tests positive for the disease, and they are made aware, they will work with the member's medical team and public health authorities to help facilitate access to appropriate care.
Diagnostic testing and associated care will be covered in accordance with the terms of your client's health plan.
As you know, this situation is evolving and should there be any significant changes, UHC will update you accordingly.
For More Information
UnitedHealthcare is providing the following resources and tools to help you stay informed.
For further questions, please contact a member of your b&p Sales Team - 888.722.3373.